Molecular Mining Enters Drug Target Discovery Collaboration with Cytochroma

May 01, 2001

NEW YORK, May 1 - Molecular Mining is using its data mining software in a collaboration with Cytochroma, a Canadian company that uses genomic information to identify and develop drugs that target cytochrome p450 enzymes, the companies said Tuesday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Corn's Complex Path

A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.

This Week in PLOS

In PLOS this week: MYRF variant linked to congenital diaphragmatic hernia, analysis of the "dragon's blood" red resin produced by traditional medicine plants, and more.

Five and Gone

CNBC reports that half of academic researchers leave after about five years.

From Within the Swamp

Researchers have used genetic analysis to confirm a new type of salamander, the New York Times reports.

Main menu